HOME | COUNTRIES | CITIES | COMPANIES | SPORTS | CARS
news videos images websites wiki
 

Genentech NEWS

NFE/5.0en-USnews-webmaster@google.com2019 Google Inc.Wed, 16 Jan 2019 18:31:59 GMTGoogle News
Adaptive Biotechnologies to Leverage Genentech, Microsoft Deals to Advance Immune Profiling Business  GenomeWeb

SAN FRANCISCO (GenomeWeb) – Adaptive Biotechnologies plans to become "the global leader" in immune profiling and designing customized therapeutics, ...

GenomeWeb
How Genentech, Badger Balm and Dr. Bronner's use sustainability to improve the environment and company culture  GreenBiz

The following is an excerpt from "Green Wisdom: A Guide for Anyone to Start, Engage and Energize a Sustainability Team," authored by Nikki Pava (foreword for ...

GreenBiz
Genentech Cutting More Jobs in Bay Area  BioSpace

On December 19, South San Francisco-based Genentech, a Roche company, filed with the State of California, indicating it planned to cut 83 jobs.

BioSpace
Charter seeking to ferry Genentech workers from San Leandro dock  East Bay Times

SAN LEANDRO — Genentech workers could commute to work from the San Leandro marina on a private ferry if the city approves the charter company's request.

East Bay Times
Adaptive Biotechnologies announces $300M licensing deal with Genentech  Puget Sound Business Journal (Seattle)

Seattle-based Adaptive Biotechnologies is licensing its core technology to California-based Genetech to develop, manufacture and commercialize personalized ...

Puget Sound Business Journal (Seattle)
In search for tiny cellular signals of cancer, Genentech closes $300M deal  San Francisco Business Times

Like many cancer-fighting companies, Genentech Inc. is looking for the tiniest signals of cancer to target with drugs — and a $300 million-plus deal with a Seattle ...

San Francisco Business Times
Adaptive and Genentech ink collaboration worth up to $2 billion  The Pharma Letter

Washington, USA-based immunotherapy specialist Adaptive Biotechnologies has entered into a global development and licensing deal with Roche subsidiary ...

The Pharma Letter
Genentech, system upgrade high on Solano assessor-recorder’s 2019 to-do list  Fairfield Daily Republic

FAIRFIELD — Marc Tonnesen has worn the hats of the assessor-recorder and assistant assessor-recorder before. He will start 2019 with the same dual role, but ...

Fairfield Daily Republic
Genentech Licenses Non-CF Compound From Proteostasis in $100 Million-Plus Deal  BioSpace

Proteostasis Therapeutics, based in Boston, signed a worldwide, exclusive license deal with Genentech for rights to a possible small molecule modulator within ...

BioSpace
Global Plasminogen Market 2019 - Genentech (Roche), Boehringer Ingelheim, Kyowa Hakko Kirin  Industry News Alert

The global “Plasminogen Market” report delivers a comprehensive and systematic framework of the Plasminogen market at a global level that includes all the ...

Industry News Alert
How an East Bay cancer fighter — once kicked to the curb by Big Pharma — picked up its 4th drug approval  San Francisco Business Times

Even in the days after Bristol-Myers Squibb Co. threw an experimental cancer drug back to Exelixis Inc. nearly a decade ago, there were signs of hope: strong ...

San Francisco Business Times
Pfizer, Genentech Agree to End Herceptin Patent Disputes  Bloomberg Law

Pfizer Inc. and Roche subsidiary Genentech Inc. agreed to end an administrative dispute over patents related to Genentech's blockbuster cancer drug Herceptin.

Bloomberg Law
Layoffs hit Instacart, Genentech, Rolls-Royce and other SF employers - San Francisco Business Times  San Francisco Business Times

Across the Bay Area, pink slips were flying at Genentech, Rolls-Royce, Instacart, Oakland International Airport concessionaire HMSHost, Infinera, Spectra ...

San Francisco Business Times
Global Anaplastic Astrocytoma Market 2025 – Key Players (Genentech, Isarna Therapeutics, Axelar, Pfizer, Amgen, Novartis, Avid Bioservices, EirGen Pharma, Boehringer Ingelheim, Celldex Therapeutics)  openPR

Global Anaplastic Astrocytoma Market report is designed in a method that helps readers to acquire a complete knowledge about the overall market scenario for ...

openPR
BRIEF-Adaptive Biotechnologies To Enter Into Worldwide Collaboration & License Agreement With Genentech  Reuters

Jan 4 (Reuters) - Adaptive Biotechnologies: * ADAPTIVE BIOTECHNOLOGIES TO ENTER INTO WORLDWIDE COLLABORATION AND LICENSE AGREEMENT ...

Reuters
Global Humatrope Market 2019 intelligence by Players: Genentech, Inc. (US), Ferring Holding SA (Switzerland), Eli Lilly and Company (US), Merck Serono SA (Switzerland), Teva Pharmaceutical Industries Limited (Israel) & More  Bitcoin Journal

Industrial Forecast on Humatrope Market: A new research report titled, 'Global Humatrope Market Size, Status and Forecast 2019-2023' have been added by ...

Bitcoin Journal
Genitourinary Drugs Industry 2019-2024 Current scenario By Novartis AG, Genentech  reportsherald.com

2019-2024 Global Genitourinary Drugs Market Study. Global Genitourinary Drugs Market Research report presents a comprehensive overview, market shares, ...

reportsherald.com
Global Egg Allergy Market Forecast 2025 Player Like: Genentech, Inc., Novartis AG., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Bayer AG, Abbott, Astellas, Sanofi, Merck & Co., Inc., Creative Diagnostic Medicare Pvt. Ltd., and ImmuneTech  Journal Dairy

The report on the “Global Egg Allergy Market” is a comprehensive overview of the market, covering various aspects such as product definition, segmentation ...

Journal Dairy
NIIMBL Announces New Projects and Funding for Biopharma Manufacturing  BioPharm International

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) revealed 22 new projects and funding aimed to advance US ...

BioPharm International
Who's the Boss? Companies and Their Novel Drug Approvals, 2014-2018  BioSpace

In 2018, the U.S. Food and Drug Administration (FDA) approved 59 novel drugs, meaning approved new molecular entities (NMEs). The figure for 2017 was 46 ...

BioSpace
Proteostasis Therapeutics's Global License Agreement with Genentech  Global Legal Chronicle

Goodwin advised Proteostasis Therapeutics on its worldwide, exclusive license agreement with Genentech for rights to potential therapeutic small molecule ...

Global Legal Chronicle
Omalizumab linked to improved disease activity in SLE  Healio

Omalizumab is well tolerated and associated with improved disease activity in patients with systematic lupus erythematosus, according to data published in ...

Healio
FDA Issues Warning on Risky Stem Cell Therapies  WebMD

Hundreds of clinics touting unapproved stem cell treatments have sprung up across the United States. But shoddy oversight may have led some hopeful patients ...

WebMD
Global Meningioma Drug Market 2019 – Eli Lilly and Co, Genentech Inc, Arno Therapeutics Inc, AstraZeneca Plc  Crypto News

Global Meningioma Drug Market Research Report conveys an explicit and intact analysis of current sitch, key vendors, competitive landscape, driving factors, ...

Crypto News
Newswire & Press Release / FDA Approves Genentech's Tecentriq in Combination with Avastin and Chemotherapy - Pharma / BioTech / Nutrition - Genentech, Inc.  Newswire Today

FDA Approves Genentech's Tecentriq in Combination With Avastin and Chemotherapy for the Initial Treatment of People With a Specific Type of Metastatic Lung ...

Newswire Today
ZappRx Inks Agreement with Leading Global Biopharma Company to Work Together in Idiopathic Pulmonary Fibrosis, Allergic Asthma, and Chronic Idiopathic Urticaria.  Business Wire

ZappRx announced today that it has entered into an agreement with Genentech. The agreement will start by seeking to improve patient access to specialt.

Business Wire
2018 in review: Portland's most-read tech, startup stories  Portland Business Journal

Filled with “must read” stories, industry news and reporter insights, exclusive interviews with local business leaders, and expanded Top 25 Lists.

Portland Business Journal
JHL Forges Ahead With Phase 3 Study of Embattled Rituximab Biosimilar  The Center for Biosimilars

Chinese drug developer JHL Biotech has announced that it randomized its first patient in a phase 3 study of JHL1101, a proposed biosimilar rituximab ...

The Center for Biosimilars
2019 Ophthalmology Drugs Market By Key Players Pfizer, Valeant, Bayer, Genentech, Novartis, Regeneron, Shire 2024  Bitcoin Journal

Ophthalmology Drugs research report provides size of the global Ophthalmology Drugs Market for the base year 2018 and the forecast between 2019 and 2024.

Bitcoin Journal
Global Anticoagulation Therapy Market By 2019-2026| Industry Top Players- Abbott., Baxter., AstraZeneca, Bayer AG, Boehringer Ingelheim International GmbH, Eli Lilly and Company, Bristol-Myers Squibb Company, Merck & Co. Inc., Genentech Inc.,  Journal Dairy

Global anticoagulation therapy market is an estimated value of USD 47.41 billion by 2026, registering a CAGR of 8.01% in the forecast period of 2019-2026.

Journal Dairy
Pulmonary Embolism Treatment Market by drug class, route of administration, Distribution Channel and Geography. Market Leaders are Accu-Break Pharmaceuticals, Daiichi Sankyo Company, Dong-A Socio Holdings, Hoffmann-La Roche, Genentech, Janssen Pharmaceuti  openPR

Precision Business Insights (PBI) in its report titled “Pulmonary Embolism Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis ...

openPR
Longevity startup Alkahest is studying young blood to make drugs for diseases of aging  INSIDER

A startup called Alkahest is studying the anti-aging effects of young blood to design drugs that could fight age-related diseases like Alzheimer's and Parkinson's.

INSIDER
‘Marketers are having a field day’: Patients stuck in corporate fight against generic drugs  The Washington Post

Health-care and government officials are growing concerned that the makers of the most advanced drug therapies are using scare tactics to ward off emerging ...

The Washington Post
BRIEF-Oncbiomune Announces Former Puma Biotechnology Executive And Genentech Veteran Brian Barnett, M.D., As Chief Executive Officer  Reuters

Jan 9 (Reuters) - OncBioMune Pharmaceuticals Inc: * ONCBIOMUNE ANNOUNCES FORMER PUMA BIOTECHNOLOGY EXECUTIVE AND GENENTECH ...

Reuters
Roche vet named Gilead CEO — and Genentech boss moves to Switzerland — in shuffle of top Bay Area biotech execs  San Francisco Business Times

As Daniel O'Day takes the helm of Gilead, replacing longtime Chairman Bill Martin and CEO Bill Milligan, Roche will moves Genentech CEO into O'Day's old ...

San Francisco Business Times
Patients stuck as drug companies fight over generic versions of advanced biologic therapies  The Seattle Times

Although they have been available in Europe for years, driving down costs for consumers across the Atlantic, unbranded versions of biologic drugs are still ...

The Seattle Times
Progressive Pathways in Treating Neovascular Retinal Disease: Exploring Tie2  Healio

Education Lab | Progressive Pathways in Treating Neovascular Retinal Disease: Exploring Tie2.

Healio
Genetic Engineering Market 2019 Analysis - Research Covers Top 10 Players as Genentech Inc., Horizon Discovery Group Plc., Thermo Fisher Scientific Inc. , Lonza Group Ltd., Integrated DNA Technologies Inc.  openPR

Market Synopsis The Global Genetic Engineering Market is presumed to expand at 14.5 % CAGR during the forecast period (2018-2027) owing to the growing ...

openPR
Roche Taps Genentech Chief to Lead Pharmaceuticals Division  The Wall Street Journal

Roche Holding appointed Bill Anderson, head of its Genentech unit, to lead the company's broader pharmaceuticals business, elevating an insider at a critical ...

The Wall Street Journal
Global Angiogenesis Modulators Market Overview 2019-2025: Celgene Co., Eisai Co., Amgen, Inc., Genentech, Inc.  Market News Press Release

MarketInsights added a new 110+ pages research report with TOC (Table of Contents) titled “Angiogenesis Modulators Market: Global Industry Analysis, Size, ...

Market News Press Release
Top Scenario: Allergy Treatment Market By Key Players: Allergopharma, Allergy Therapeutics, Alerpharma SA, Allergon AB, Genentech Inc., Allergan, Inc. 2024  openPR

Global Allergy Treatment Market: Overview An allergy is an immune system's sharp sensitivity. An allergy happens when a foreign material that is risk-free in ...

openPR
MS Therapy Ocrevus Also Depletes Certain T-cells in Patients, Study Says  Multiple Sclerosis News Today

A single dose of Ocrevus (ocrelizumab) depleted immune T-cells within two weeks in patients with relapsing and primary progressive MS, a study shows.

Multiple Sclerosis News Today
Genentech Cuts 223 Jobs at Its Bay Area HQ  BioSpace

Genentech is slashing 223 jobs at its South San Francisco headquarters, according to a Worker Adjustment and Retraining Notification posted on a California ...

BioSpace
Genentech staff 'funneled secrets to Taiwan biosimilar firm,' prosecutors say  FierceBiotech

Genentech is the latest biopharma company to be involved in an industrial espionage case, with four former U.S. researchers accused of passing sensitive ...

FierceBiotech
Foundation Medicine Announces Executive Leadership Transition  Business Wire

Foundation Medicine, Inc. today announced the appointment of Cindy Perettie as chief executive officer, effective February 4, 2019. Ms. Perettie will.

Business Wire
Kidney Cancer Drugs Market 2019 Top Clinical Manufacturers (Abbott Laboratories, Glaxosmithkline, Novartis, Bayer, Active Biotech, Amgen, Cipla, Genentech, Prometheus Laboratories, Exelixis, Onyx Pharmaceuticals, Aveo Pharmaceuticals, Immatics Biotechnolo  openPR

Global Kidney Cancer Drugs Market Size, Status and Forecast 2019-2025: This report focuses on the global Kidney Cancer Drugs status, future forecast, growth ...

openPR
Kidney Cancer Drugs Industry, Top Services by Pfizer Inc., Novartis International AG, Genentech, Inc., Active Biotech AB, Amgen Inc., Bayer AG, Cipla Limited, Hoffmann-La Roche AG, Bristol-Myers Squibb Company, Eisai Co., Ltd. and Exelixis  openPR

Various key drug manufacturers are increasingly gaining regulatory drug approval for the treatment of renal cell carcinoma. These key players are launching ...

openPR
Genentech Takes Aim at NASH, Acquires Jecure Therapeutics  BioSpace

Roche subsidiary Genentech snaps up Jecure and its portfolio of preclinical NLRP3 inhibitors aimed at serious inflammatory diseases.

BioSpace
Exclusive: Genentech to open Portland office, brings 300 jobs  Portland Business Journal

The biotechnology company evaluated 10 other cities before selecting Portland.

Portland Business Journal
Genentech details claims Sanofi partner JHL used stolen trade secrets to develop rival drugs at an 'astonishing pace'  Endpoints News

The feds recently rounded up and charged a group of four, including a longtime senior scientist, with stealing trade secrets from Genentech in South San ...

Endpoints News
Genentech plans office in Lloyd District  OregonLive.com

Genentech says it will open an office in Portland's Lloyd District and hire 300 people. The California company, owned by the Swiss-based Roche Group, already ...

OregonLive.com
Recombinant DNA Technology Market to Witness Huge Growth by 2025 | F. Hoffmann-La Roche Ltd (Genentech, Inc), Profacgen  Market News Biz

HTF MI recently Announced Global Recombinant DNA Technology study with 100+ market data Tables and Figures spread through Pages and easy to ...

Market News Biz
Genentech Flu Drug Scores Another Late-Stage Win  BioSpace

With flu season fast approaching, Genentech has some good news for people who are at high risk of complications from the illness.

BioSpace
Outcome Health Announces First-ever Chief Compliance Officer  PRNewswire

CHICAGO, Jan. 16, 2019 /PRNewswire/ -- Outcome Health, a healthcare innovation company focused on evolving the point of care experience for patients and ...

PRNewswire
Remembering John Mendelsohn, a Pioneer of Targeted Therapy for Cancer  On Cancer - Memorial Sloan Kettering

Former MSK physician-scientist John Mendelsohn, who served the institution in multiple roles from 1985 to 1996, died on January 7 from brain cancer.

On Cancer - Memorial Sloan Kettering
The FDA Just Approved the First New Flu Drug in 20 Years—And Is Nearing an All-Time Drug Approval Record  Fortune

The FDA on Wednesday approved Genentech and Shionogi's new flu drug. The agency is now on pace to have a record breaking year of approvals.

Fortune
Want a lower tax bill? So do Apple and Genentech  San Francisco Chronicle

For-profit companies don't typically downplay the value of their assets. But when it comes to paying property taxes, some of Silicon Valley's largest companies ...

San Francisco Chronicle
Ophthalmology Disease & Epidemiology Overview 2018 Featuring Alimera Sciences, Allergan, Regeneron, Bayer, Santen, Roche, Genentech, & Novartis - ResearchAndMarkets.com  Financialbuzz.com

The "Ophthalmology - Disease & Epidemiology Overview" report from Decision Resources Group has been added to ResearchAndMarkets.com's offering.

Financialbuzz.com
Genentech Sues JHL for Criminal Theft of Trade Secrets in Civil Court  The Center for Biosimilars

In late October 2018, former Genentech employees were charged with criminal theft for conspiring to steal trade secrets to assist biosimilar developer JHL ...

The Center for Biosimilars
Global Clotting Factor Market Insights Report 2018 – Sanofi S.A. , Genentech , Kemwell Biopharma , Biocon  Daily News Insights

The global “Clotting Factor” market research report concerns Clotting Factor market by taking into consideration various factors such supply chain, demand, size, ...

Daily News Insights
PEGylated Protein Therapeutics - Worldwide Analysis & Outlook to 2025: A $17.8 Billion Opportunity - ResearchAndMarkets.com  Business Wire

DUBLIN--(BUSINESS WIRE)--The "PEGylated Protein Therapeutics Market by Product Type, By Application By Sales Channel - Global Opportunity Analysis and ...

Business Wire
Genentech Seeks to Bar JHL From Developing 3 Biosimilars  The Center for Biosimilars

Last month, former Genentech employees were charged with conspiring to steal trade secrets to assist biosimilar developer JHL Biotech in developing its ...

The Center for Biosimilars
Roche's Genentech to cut 223 jobs in California  Becker's Hospital Review

Genentech, a subsidiary of Swiss pharma giant Roche, is slashing 223 jobs from its headquarters in California, according to a recent WARN notice. The layoffs ...

Becker's Hospital Review
Global Drugs for Melanoma Market Overview 2019-2025: Amgen, Bristol-Myers Squibb, Roche, Genentech, Janssen Biotech  Market News Press Release

Market study report entitled “Global Drugs for Melanoma Market 2019 Industry Research Report” recently published on MarketInsights is the crucial document for ...

Market News Press Release
Genentech I/O chief Dan Chen heads to an upstart biotech looking to create a landmark advance on antibodies  Endpoints News

One of the top scientific leaders behind the emergence of PD-1/L1 checkpoint inhibitors has left Genentech to take the chief medical officer's job at a low-profile ...

Endpoints News
MANF identified as a rejuvenating factor in parabiosis  Science Daily

Older mice who are surgically joined with young mice in order to share a common bloodstream get stronger and healthier, making parabiosis one of the hottest ...

Science Daily
Genentech to pay Immunocore $100M to co-develop preclinical MAGE-A4 drug  FierceBiotech

Genentech has put up $100 million (€88 million) in upfront and near-term milestone payments to co-develop an anticancer bispecific antibody with Immunocore.

FierceBiotech
Genentech and Pfizer Reach Settlement Over Biosimilar Trastuzumab  The Center for Biosimilars

Recently, plaintiff Genentech and defendant Pfizer filed a collective stipulation and proposed order of dismissal of a patent infringement lawsuit over ...

The Center for Biosimilars
FDA to "take action" against branded drug makers using scare tactics to thwart biosimilar competition  Seeking Alpha

In a tweet, FDA Commissioner Scott Gottlieb, M.D. says the agency is concerned with branded drugmakers' activities toward the encroachment of biosimilars o.

Seeking Alpha
As biosimilars loom, Roche's Genentech plans to lay off 223 staffers in California  FiercePharma

As Roche braces for the biosimilar assault on blockbuster cancer drugs, its Genentech unit is parting ways with 223 staffers in California.

FiercePharma
Genentech builds new office in Oregon after trimming HQ staff; Researchers laud ketamine as a replacement for opioids  Endpoints News

... → Two months after slashing 223 staffers from its headquarters in South San Francisco, Genentech says it will open up a new unit in Portland, OR, that will ...

Endpoints News
Genentech Makes Generous Offer to British Immuno-Oncology Company Immunocore  Labiotech.eu

Immunocore and the US biotech giant Genentech are building on their existing partnership to boost the clinical development of Immunocore's immunotherapy for ...

Labiotech.eu
Former Genentech employees are arrested on charges they stole trade secrets  STAT

Three former Genentech employees were arrested for allegedly stealing trade secrets and funneling the confidential information to a company in Taiwan, ...

STAT
Genentech to slash 223 San Francisco jobs  The Pharma Letter

The Genentech unit of Swiss pharma giant Roche is to cut 223 jobs at its headquarters in San Francisco, USA.

The Pharma Letter
Championed by AbbVie, immuno-neurology player Alector maps $150M IPO  Endpoints News

Endorsed by AbbVie, and under the leadership of Genentech veteran Arnon Rosenthal, San Francisco-based biotech Alector has charted a path toward a $150 ...

Endpoints News
Genentech to Present New Positive Data from Its Broad Cancer Immunotherapy Program and across a Wide Range of Cancers at the European Society for Medical Oncology (ESMO) 2018 Congress  Business Wire

Positive data for both Alecensa® in lung cancer and Tecentriq in lung and liver cancers –. – New pivotal results from the tumor-agnostic entrectinib study across ...

Business Wire
Genentech antibiotic quells resistance | Research  Chemistry World

With bacteria becoming resistant to antibiotics and therefore increasingly deadly, US researchers have developed 'a much-needed new class' of drug. Medicinal ...

Chemistry World
Sanofi, Genentech Both Eye US Expansions; Could Add up to 2300 Jobs  BioSpace

Two well-established pharma companies are expanding in two different U.S. cities. One city is known for the plethora of pharma and biotech jobs, while the other ...

BioSpace
Apple, Genentech hold up Silicon Valley for billions on property tax  Curbed SF

Silicon Valley's boom times mean that county coffers are booming too, as all of that private success can lead to a fat annual bill when it's time to pay the taxman.

Curbed SF
Bio-Thera Solutions Ltd Partners with Cipla Ltd to Market Key Cancer Biosimilar  Business Wire

Bio-Thera Solutions announces a licensing agreement with Cipla Limited for BAT1706, its bevacizumab biosimilar, for select emerging markets.

Business Wire
Affimed Announces Collaboration with Genentech to Develop Novel NK Cell Engager-based Immunotherapeutics for Multiple Cancer Targets  GlobeNewswire

Affimed will receive $96 million upfront and committed funding and is eligible for up to an additional $5.0 billion including milestone payments, and royalties on ...

GlobeNewswire
BRIEF-Roche's Pharmaceuticals Head To Be Replaced By Genentech CEO  Reuters

Dec 10 (Reuters) - Roche Holding AG: * CHANGES TO THE ROCHE CORPORATE EXECUTIVE COMMITTEE. * DANIEL O'DAY, CEO ROCHE ...

Reuters
HDSA FAQ on the Roche/Genentech RG6042 program  HDBuzz

HDSA's frequently asked questions factsheet about the huntingtin-lowering trial ASO program was so good we stole it (with permission) ...

HDBuzz
Genentech's inhaled JAK1 inhibitor shows promise as a localized treatment for asthma  FierceBiotech

Numerous JAK inhibitors have been developed to treat inflammatory diseases. To avoid some common side effects seen in systemic JAK inhibition, Genentech ...

FierceBiotech
FDA Nod For GNMK, AKRX Gets New CEO, PTI Plunges After-hours  Nasdaq

Today's Daily Dose brings you news about FDA nod for GenMark Diagnostics' ePlex Blood Culture Identification Gram-Positive Panel; Akorn appointing a.

Nasdaq
New Flu Season, New Flu Drug from Genentech  BioSpace

Last year's influenza season in the U.S. had record-breaking hospitalization rates. A lot of industry observers are looking at a new flu drug, baloxavir marboxil, ...

BioSpace
Biosimilars 2018 Year in Review | Fish & Richardson  JD Supra

Eight years have passed since the enactment of the Biologics Price Competition and Innovation Act (BPCIA), and the biosimilars industry has continued to grow.

JD Supra
Former Genentech Employees Charged With Stealing Trade Secrets for Biosimilar Competitor JHL  The Center for Biosimilars

According to a statement issued October 29 by the United States Attorney's Office in San Francisco, former Genentech employees were charged with conspiring ...

The Center for Biosimilars
Citing 'brazen' trade secrets theft, Genentech sues indicted ex-employees and biosim maker  FiercePharma

Genentech filed a lawsuit against former employees accused of stealing trade secrets for developing and producing some of its top drugs, calling on a court to ...

FiercePharma
Genentech, Horizon Earn Spots on List of 'Companies That Care'  BioSpace

Genentech and Horizon Pharma were the only two biopharma companies that made People's 2018 list of “50 Companies That Care,” a list that highlights how a ...

BioSpace
Genentech offers array of services to MS patients  Daily Democrat

Genentech created a new resource page to assist thousands residents living with multiple sclerosis by connecting them with companies and resources to help ...

Daily Democrat
FDA Approves Genentech's Hemlibra (Emicizumab-kxwh) for Hemophilia A Without Factor VIII Inhibitors  Business Wire

Only medicine that can be self-administered subcutaneously once weekly, every two weeks or every four weeks for hemophilia A with and without factor VIII ...

Business Wire
This New Single Dose Flu Drug Could Be Coming to the U.S. Before the Next Flu Season  Fortune

A novel new single dose flu drug by Genentech has received an FDA priority review. The drug could hit the US market in time for flu season.

Fortune
Hotbed Report: A Look at the Life Science Industry in the City by the Bay | BioSpace  BioSpace

With more than 82500 employees working in the sector, California's Bay Area is one of the strongest homes for biotech companies in the world.

BioSpace
Genentech Acquires Jecure Therapeutics  Business Wire

Jecure Therapeutics Inc., a biotechnology company with novel drug discovery programs targeting serious inflammatory diseases, today announced a defini.

Business Wire
FDA approves Genentech drug for lung cancer  MarketWatch

Genentech, a member of the Roche Group, on Thursday said the U.S. Food and Drug Administration approved Tecentriq and chemotherapy for some patients ...

MarketWatch
Genentech's Tecentriq Continues to Demonstrate Its Potency as a Treatment for Lung Cancer  BioSpace

This morning, Genentech released results of its Phase III IMpower 133 trial that showed treatment with Tecentriq plus chemotherapy helped people with ...

BioSpace
Celltrion and Teva Snag Second Biosimilar Approval of a Genentech Drug  BioSpace

The U.S. Food and Drug Administration approved another biosimilar. On Friday, the regulatory agency approved Herzuma, a biosimilar to Genentech's ...

BioSpace
Genentech, Microbiotica to Develop Microbiome-Based IBD Treatments  Genetic Engineering & Biotechnology News

Genentech, a member of the Roche Group, will partner with Microbiotica to discover, develop, and commercialize microbiome-based biomarkers and therapies ...

Genetic Engineering & Biotechnology News
 

Genentech Videos

Genentech
02:09:07
Genentech
Discovering Talent for Genentech
22:50:09
Discovering Talent for Genentech
Genentech Job Shadow Day
23:08:42
Genentech Job Shadow Day
How Biotech Began--The Story of Genentech
20:12:47
How Biotech Began--The Story of Genentech
Genentech's story
23:13:41
Genentech's story
Oncology Biomarker Development at Genentech
22:00:02
Oncology Biomarker Development at Genentech
Process Development Rotational and Internship Programs
19:47:39
Process Development Rotational and Internship Programs
Genentech’s Herbert W. Boyer and Bill Anderson I Fortune
18:50:40
Genentech’s Herbert W. Boyer and Bill Anderson I Fortune
Genentech Expose - Rob Bennett’s Story
06:22:10
Genentech Expose - Rob Bennett’s Story
Kanu Sharma, MD, MBA., Pharma Portfolio Management, Roche/Genentech
04:49:55
Kanu Sharma, MD, MBA., Pharma Portfolio Management, Roche/Genentech
 

Genentech Images

Biomedical Computation at Stanford :: 2010
Biomedical Computation at Stanford :: 2010
File:Genentech HQ building 32.JPG - Wikimedia Commons
File:Genentech HQ building 32.JPG - Wikimedia Commons
File:Genentech HQ building 33.JPG - Wikimedia Commons
File:Genentech HQ building 33.JPG - Wikimedia Commons
File:Genentech.svg - Wikipedia
File:Genentech.svg - Wikipedia
Roche, Genentech sued for allegedly overfilling Herceptin ...
Roche, Genentech sued for allegedly overfilling Herceptin ...
OCREVUS Dosage & Rx Info | Uses, Side Effects
OCREVUS Dosage & Rx Info | Uses, Side Effects
FDA Clears Ranibizumab Injection in a Prefilled Syringe
FDA Clears Ranibizumab Injection in a Prefilled Syringe
Ado-trastuzumab Emtansine (Kadcyla®) Drug Description ...
Ado-trastuzumab Emtansine (Kadcyla®) Drug Description ...
Strategic Forecasting
Strategic Forecasting
FDA Supports Hemophilia A treatment ACE910
FDA Supports Hemophilia A treatment ACE910
 

Genentech WebSites

 

Genentech Wiki

Genentech, Inc., is a biotechnology corporation which became a subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche.As of September 2017, Genentech employed 15,064 people.